The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
The effects of nicotine on locomotor activity in non‐tolerant and tolerant rats
Open accessAbstract
1--Rats were tested for locomotor activity in photocell cages, for 80 min starting immediately after subcutaneous injection of (-)-nicotine bitartrate or 0.9% w/v NaCl solution (saline). In non-tolerant subjects, nicotine (0.1 to 0.4 mg/kg base) depressed activity and induced ataxia in the first 20 min, but increased activity later in the session; these actions were dose-dependent. 2--Tolerance was studied by comparing rats given nicotine (0.4 mg/kg s.c.) every day with control rats given saline instead. Each week, every subject was tested once with nicotine (0.4 mg/kg) and once with saline. With daily or even weekly injections of nicotine, the initial depressant action of the drug was replaced by a dose-dependent stimulant action which occurred throughout the session. In these tolerant animals, little ataxia was seen except when a larger dose of 0.8 mg/kg was given. Tolerance to the depressant action of nicotine persisted for at least 3 weeks. 3--In non-tolerant subjects, mecamylamine (0.5, 1.0 mg/kg s.c.) prevented the initial depressant action of nicotine (0.4 mg/kg). In tolerant rats, the locomotor stimulant action of nicotine (0.4 mg/kg) was prevented by mecamylamine (0.1, 0.32, 1.0 mg/kg s.c.) in a dose-related way; the quaternary ganglion blocker, hexamethonium (0.2, 1.0, 5.0 mg/kg s.c.) had little or no such effect. Neither mecamylamine nor hexamethonium altered activity when given alone. 4--It is suggested that a few treatments with nicotine can unmask a stimulant action of the drug, probably of central origin, which possibly reflects a stimulation of nicotine receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For nicotine, animal studies have shown that repeated intermittent injections of nicotine typically cause sensitization or enhancement of the drug’s locomotor activating effects (L. K. Baker et al., 2013; Benwell & Balfour, 1992; Clarke & Kumar, 1983; Vezina, McGehee, & Green, 2007).”
From Cued for Risk: Evidence for an Incentive Sensitization Framework to Explain the Interplay between Stress and Anxiety, Substance Abuse, and Reward Uncertainty in Disordered Gambling Behavior (2019) · cites this paper as Clarke & Kumar, 1983
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Psychopharmacology: A Generation of Progress
Ananth, J. (1979) · Psychosomatics · doi:10.1016/s0033-3182(79)73729-7 · Cited by 845
Persistent Behavior at High Rates Maintained by Intravenous Self-Administration of Nicotine
Goldberg, S. R., Spealman, R. D., & Goldberg, D. M. (1981) · Science · doi:10.1126/science.7291998 · Cited by 347
Ascher, P., Large, W. A., & Rang, H. P. (1979) · The Journal of Physiology · doi:10.1113/jphysiol.1979.sp012958 · Cited by 296
Acute and chronic tolerance to nicotine measured by activity in rats
Stolerman, I. P., Fink, R. S., & Jarvik, M. E. (1973) · Psychopharmacology · doi:10.1007/bf00429192 · Cited by 246
Paradoxical tranquilizing and emotion-reducing effects of nicotine.
Gilbert, D. G. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.4.643 · Cited by 217
Tobacco Alkaloids and Related Compounds
(1967) · Food and Cosmetics Toxicology · doi:10.1016/s0015-6264(67)82893-1 · Cited by 159
Nicotine tolerance in rats; role of dose and dose interval
Stolerman, I. P., Bunker, P., & Jarvik, M. E. (1974) · Psychopharmacology · doi:10.1007/bf00422555 · Cited by 121
The occurrence of tolerance to a central depressant effect of nicotine
Morrison, C. F., & Stephenson, J. A. (1972) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1972.tb06857.x · Cited by 119
Stone, C. A., Torchiana, M. L., Navarro, A., & Beyer, K. H. (1956) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11667-4 · Cited by 110
Bättig, K., Driscoll, P., Schlatter, J., & Uster, H. J. (1976) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(76)90060-5 · Cited by 96
Research works printed but not linked: 7
- Barthelemy C., 1970, Comparison de divers antagonistes de l'eserine et de la nicotine chez la souris, J. Pharmac., (Paris), 1, 369
- Clarke P.B.S., 1981, Effects of nicotine on intracranial self‐stimulation in non‐tolerant rats, Br. J. Pharmac., 74, 212P
- Cox D.R., 1958, Planning of Experiments.
- Nelson W.T., 1982, Nicotine self‐administration in rat, Pharmac. Biochem. Behav., 15, 833
- Rosecrans J.A., 1969, Effects of nicotine on exploratory behaviour of female rats, Pharmacologist, 11, 246
- Schlatter J., 1978, Int. Workshop Behav. Effects of Nicotine, 55
- StTtzer M., 1970, Effects of nicotine on fixed interval behaviour and modification by cholinergic antagonists, J. Pharmac. exp. Ther., 171, 165
Cited by
Sorted by citations
Items 101–200 of 449
Alteration of the Behavioral Effects of Nicotine by Chronic Caffeine Exposure
Tanda, G., & Goldberg, S. R. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00234-3 · Cited by 82
Apparent absence of nicotine-induced conditioned place preference in rats
Clarke, P. B. S., & Fibiger, H. C. (1987) · Psychopharmacology · doi:10.1007/bf00215484 · Cited by 82
Self-citationJanhunen, S. K., & Ahtee, L. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.09.008 · Cited by 83
Booze, R. M. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00169-0 · Cited by 81
Helton, D. R., Modlin, D. L., Tizzano, J. P., & Rasmussen, K. (1993) · Psychopharmacology · doi:10.1007/bf02245698 · Cited by 81
Miller, D. K., Wilkins, L. H., Bardo, M. T., Crooks, P. A., & Dwoskin, L. P. (2001) · Psychopharmacology · doi:10.1007/s002130100747 · Cited by 80
Collins, A. C., Romm, E., & Wehner, J. M. (1990) · Brain Research Bulletin · doi:10.1016/0361-9230(90)90222-l · Cited by 79
Bevins, R. A., Besheer, J., & Pickett, K. S. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00451-2 · Cited by 78
Nicotine-induced Attentional Enhancement in Rats Effects of Chronic Exposure to Nicotine
Hahn, B. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00348-2 · Cited by 78
Dw, S., Loring, R., Aizenman, E., & Zigmond, R. (1991) · Journal of Neuroscience · doi:10.1523/jneurosci.11-01-00287.1991 · Cited by 78
Mesolimbic Dopamine Activation—The Key to Nicotine Reinforcement?
Clarke, P. B. S. (2007) · Novartis Foundation symposium · doi:10.1002/9780470513965.ch9 · Cited by 78
Self-citationMitchell, S. N., Brazell, M. P., Joseph, M. H., Alavijeh, M. S., & Gray, J. A. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90440-8 · Cited by 76
Smith, K., Mitchell, S. N., & Joseph, M. H. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb06377.x · Cited by 75
Nicotinic receptors and Parkinson's disease
Quik, M., & Jeyarasasingam, G. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00888-2 · Cited by 74
Investigations using immunization to attenuate the psychoactive effects of nicotine
Carrera, M. R. A., Ashley, J. A., Hoffman, T. Z., Isomura, S., Wirsching, P., Koob, G. F., & Janda, K. D. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.11.029 · Cited by 73
Tolerance to nicotine following chronic treatment by injections: a potential role for corticosterone
Pauly, J. R., Grun, E. U., & Collins, A. C. (1992) · Psychopharmacology · doi:10.1007/bf02245282 · Cited by 75
MK801 attenuates behavioural adaptation to chronic nicotine administration in rats
Shoaib, M. C., & Stolerman, I. P. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09010.x · Cited by 72
Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
Collins, A. C., Bhat, R. V., Pauly, J. R., & Marks, M. J. (2007) · Novartis Foundation symposium · doi:10.1002/9780470513965.ch5 · Cited by 72
Venugopalan, V. V., Casey, K. F., O'Hara, C., O'Loughlin, J., Benkelfat, C., Fellows, L. K., & Leyton, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.135 · Cited by 70
Hahn, B., Shoaib, M. C., & Stolerman, I. P. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1438-6 · Cited by 70
King, S. L., Caldarone, B. J., & Picciotto, M. R. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.024 · Cited by 70
Olausson, P., Engel, J. A., & Söderpalm, B. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00673-6 · Cited by 69
Reversal of a Vigilance Decrement in the Aged Rat by Subtype-Selective Nicotinic Ligands
Grottick, A. J., Haman, M., Wyler, R., & Higgins, G. A. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300102 · Cited by 68
Schenk, S., Snow, S., & Horger, B. A. (1991) · Psychopharmacology · doi:10.1007/bf02244075 · Cited by 68
Pietilä, K., Lähde, T., Attila, M., Ahtee, L., & Nordberg, A. (1998) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/pl00005152 · Cited by 67
Cohen, A., & George, O. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00041 · Cited by 70
Mecamylamine blockade of nicotine responses: Evidence for two brain nicotinic receptors
Collins, A. C., Evans, C. B., Miner, L. L., & Marks, M. J. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90518-6 · Cited by 67
Nicotine tolerance: an analysis of the time course of its development and loss in the rat
Collins, A. C., Romm, E., & Wehner, J. M. (1988) · Psychopharmacology · doi:10.1007/bf02431526 · Cited by 67
Locomotor activation and dopamine release produced by nicotine and isoarecolone in rats
Whiteaker, P., Garcha, H. S., Wonnacott, S., & Stolerman, I. P. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16417.x · Cited by 66
Kita, T., Okamoto, M., & Nakashima, T. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90370-5 · Cited by 66
Hellberg, S. N., Russell, T. I., & Robinson, M. J. F. (2019) · Cognitive, Affective, & Behavioral Neuroscience · doi:10.3758/s13415-018-00662-3 · Cited by 65
“For nicotine, animal studies have shown that repeated intermittent injections of nicotine typically cause sensitization or enhancement of the drug’s locomotor activating effects (L. K. Baker et al., 2013; Benwell & Balfour, 1992; Clarke & Kumar, 1983; Vezina, McGehee, & Green, 2007).”
Larval Zebrafish Model for FDA-Approved Drug Repositioning for Tobacco Dependence Treatment
Cousin, M. A., Ebbert, J. O., Wiinamaki, A. R., Urban, M. D., Argue, D. P., Ekker, S. C., & Klee, E. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090467 · Cited by 65
Enhancement of cocaine-seeking behavior by repeated nicotine exposure in rats
Bechtholt, A. J., & Mark, G. P. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1079-1 · Cited by 65
Receptor mechanisms of nicotine-induced locomotor hyperactivity in chronic nicotine-treated rats
Fung, Y. K., & Lau, Y. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90721-2 · Cited by 65
Shim, I., Kim, H.-T., Kim, Y., Chun, B., Hahm, D., Lee, E. H., Kim, S. E., & Lee, H. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01582-0 · Cited by 64
Russell, M. A. (1989) · Progress in brain research · doi:10.1016/s0079-6123(08)62488-7 · Cited by 64
Locomotion induced by ventral tegmental microinjections of a nicotinic agonist
Museo, E., & Wise, R. A. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90316-a · Cited by 64
The role of corticosteroids in nicotine's physiological and behavioral effects
Caggiula, A. R., Donny, E. C., Epstein, L. H., Sved, A. F., Knopf, S., Rose, C., McAllister, C. G., Antelman, S. M., & Perkins, K. A. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00078-4 · Cited by 64
Kenny, P. J., Cheeta, S., & File, S. E. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00114-8 · Cited by 63
Mecamylamine does not precipitate withdrawal in cigarette smokers
Eissenberg, T., Griffiths, R. R., & Stitzer, M. L. (1996) · Psychopharmacology · doi:10.1007/s002130050094 · Cited by 62
Clarke, P. B. S. (1984) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1984.tb16517.x · Cited by 62
Self-citationSerotonin receptors as potential targets for modulation of nicotine use and dependence
Fletcher, P. J., LE, A., & Higgins, G. A. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00918-7 · Cited by 61
Acute nicotine increases both impulsive choice and behavioural disinhibition in rats
Kolokotroni, K. Z., Rodgers, R. J., & Harrison, A. A. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2296-2 · Cited by 69
Differential behavioral and neuroendocrine effects of repeated nicotine in adolescent and adult rats
Cruz, F. C., DeLucia, R., & Planeta, C. S. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.12.007 · Cited by 60
Reid, M. S., Ho, L. B., & Berger, S. P. (1996) · Psychopharmacology · doi:10.1007/bf02247381 · Cited by 60
Effects of nicotine on memory retrieval in mice
Zarrindast, M.-R., Sadegh, M., & Shafaghi, B. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00628-1 · Cited by 60
Gäddnäs, H., Pietilä, K., & Ahtee, L. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00201-1 · Cited by 60
Ivanova, S. А., & Greenshaw, A. J. (1997) · Psychopharmacology · doi:10.1007/s002130050441 · Cited by 60
Influence of Sex and Female Hormones on Nicotine-Induced Changes in Locomotor Activity in Rats
Kanýt, L., Stolerman, I. P., Chandler, C. J., Saigusa, T., & Pöğün, Ş. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00140-3 · Cited by 59
Tobacco Smoking and Nicotine Neuropsychopharmacology: Some Future Research Directions
Domino, E. F. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00193-0 · Cited by 59
Curzon, P., Nikkel, A. L., Bannon, A. W., Arnerić, S. P., & Decker, M. W. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37871-1 · Cited by 59
Horton, D. B., Potter, D. M., & Mead, A. N. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283644d2e · Cited by 60
Nicotine and nicotinic receptors in the circadian system
O’Hara, B. F., Edgar, D. M., Cao, V. H., Wiler, S. W., Heller, H. C., Kilduff, T. S., & Miller, J. D. (1998) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(97)00077-2 · Cited by 58
Boyadjieva, N. I., & Sarkar, D. K. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00444-x · Cited by 55
Lobeline attenuates locomotor stimulation induced by repeated nicotine administration in rats
Miller, D. K., Harrod, S. B., Green, T. A., Wong, M.-Y., Bardo, M. T., & Dwoskin, L. P. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00996-6 · Cited by 54
Alderson, H. L., Latimer, M. P., & Winn, P. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0174-4 · Cited by 54
Nisell, M. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00040-7 · Cited by 55
Influence of kinetics of nicotine administration on tolerance development and receptor levels
Marks, M. J., Stitzel, J. A., & Collins, A. C. (1987) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(87)90355-8 · Cited by 53
Chronic nicotine administration in the drinking water affects the striatal dopamine in mice
Pietilä, K., & Ahtee, L. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00235-5 · Cited by 50
Wellman, P. J., Clifford, P. S., Rodriguez, J. A., Hughes, S., Eitan, S., Brunel, L., Fehrentz, J., & Martínez, J. (2011) · Regulatory Peptides · doi:10.1016/j.regpep.2011.08.014 · Cited by 50
Tsutsui‐Kimura, I., Ohmura, Y., Izumi, T., Yamaguchi, T., Yoshida, T., & Yoshioka, M. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283305e65 · Cited by 50
Mansbach, R. S., Chambers, L. K., & Rovetti, C. C. (2000) · Psychopharmacology · doi:10.1007/s002130050047 · Cited by 50
Nicotine and Behavioral Sensitization
Mao, D., & McGehee, D. S. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9230-7 · Cited by 50
Acute and chronic nicotine effects on measures of activity in rats: a multivariate analysis
Ksir, C. J. (1994) · Psychopharmacology · doi:10.1007/bf02244758 · Cited by 50
Neugebauer, N. M., Zhang, Z., Crooks, P. A., Dwoskin, L. P., & Bardo, M. T. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0163-8 · Cited by 49
Microinjections of a nicotinic agonist into dopamine terminal fields: Effects on locomotion
Museo, E., & Wise, R. A. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90050-r · Cited by 49
The habenular G-protein–coupled receptor 151 regulates synaptic plasticity and nicotine intake
Antolin‐Fontes, B., Li, K., Ables, J. L., Riad, M. H., Görlich, A., Williams, M., Wang, C., Lipford, S. M., Dao, M. T., Liu, J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916132117 · Cited by 50
Comparison of the behavioral effects of cigarette smoke and pure nicotine in rats
Harris, A. C., Mattson, C., LeSage, M. G., Keyler, D. E., & Pentel, P. R. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.05.008 · Cited by 48
Olausson, P., Ericson, M., Löf, E., Engel, J. A., & Söderpalm, B. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00903-7 · Cited by 48
Place preference conditioning with ventral tegmental injections of cytisine
Museo, E., & Wise, R. A. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00656-3 · Cited by 48
Umezu, T., Yonemoto, J., Soma, Y., & Suzuki, T. (1998) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1997.8312 · Cited by 46
Olausson, P., Åkesson, P., Engel, J. A., & Söderpalm, B. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00939-6 · Cited by 46
Evidence for opioid mechanisms in the behavioral effects of nicotine
Corrigall, W. A., Herling, S., & Coen, K. M. (1988) · Psychopharmacology · doi:10.1007/bf02431529 · Cited by 46
Reckziegel, P., Boufleur, N., Barcelos, R. C. S., Benvegnú, D. M., Pase, C. S., Müller, L. G., Teixeira, A. M., Zanella, R., do Prado, A. C. P., Fett, R., et al. (2011) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2011.04.022 · Cited by 45
McCormick, C. M., & Ibrahim, F. N. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.12.012 · Cited by 45
Effects of chronic nicotine administration on locomotion depend on rat sex and housing condition
Faraday, M. M., Scheufele, P. M., Rahman, M. A., & Grunberg, N. E. (1999) · Nicotine & Tobacco Research · doi:10.1080/14622299050011251 · Cited by 45
Effects of a Novel Cholinergic Ion Channel Agonist SIB-1765F on Locomotor Activity in Rats
Menzaghi, F., Whelan, K. T., Risbrough, V. B., Rao, T. S., & Lloyd, G. K. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36403-1 · Cited by 45
Actions of octocoral and tobacco cembranoids on nicotinic receptors
Ferchmin, P. A., Pagán, O. R., Ulrich, H., Szeto, A. C., Hann, R. M., & Eterović, V. A. (2009) · Toxicon · doi:10.1016/j.toxicon.2009.02.033 · Cited by 44
Evidence for a behavioral deficit during withdrawal from chronic nicotine treatment
Corrigall, W. A., Herling, S., & Coen, K. M. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90387-0 · Cited by 44
Welzl, H., Alessandri, B., Oettinger, R., & B�ttig, K. (1988) · Psychopharmacology · doi:10.1007/bf00216057 · Cited by 44
Reavill, C. A., & Stolerman, I. P. (1987) · Journal of Psychopharmacology · doi:10.1177/026988118700100408 · Cited by 44
Behavioural Pharmacology and Neurobiology of Nicotine Reward and Dependence
Chiara, G. D. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57079-7_24 · Cited by 44
Nicotine-conditioned locomotor sensitization in rats: assessment of the US-preexposure effect
Bevins, R. A., & Palmatier, M. I. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00009-3 · Cited by 42
Mechanism-based medication development for the treatment of nicotine dependence
Xi, Z., Spiller, K. J., & Gardner, E. L. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.46 · Cited by 42
Blockade of nicotine-induced locomotor sensitization by a novel neurotensin analog in rats
Fredrickson, P. A., Boules, M., Yerbury, S., & Richelson, E. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02689-4 · Cited by 42
Recent developments in neuronal nicotinic acetylcholine receptor antagonists
Dwoskin, L. P., Xu, R., Ayers, J. T., & Crooks, P. A. (2000) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.10.10.1561 · Cited by 42
A Rodent Model for Nicotine Self-Administration
Corrigall, W. A. (2003) · Humana Press eBooks · doi:10.1385/0-89603-217-5:315 · Cited by 42
Conditioning of nicotine effects on motility and behaviour in rats
Walter, S., & Kuschinsky, K. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00165145 · Cited by 42
Kappa-opioid receptor modulation of nicotine-induced behaviour
Hahn, B., Stolerman, I. P., & Shoaib, M. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00119-2 · Cited by 39
Midde, N. M., Gomez, A. M., Harrod, S. B., & Zhu, J. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.03.013 · Cited by 39
Ferchmin, P. A., Lukas, R. J., Hann, R. M., Fryer, J. D., Eaton, J. B., Pagán, O. R., Rodrı́guez, A. D., Nicolau, Y., Rosado, M., Cortés, S., et al. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1049 · Cited by 39
Shallom, J. M., & Katyare, S. S. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90716-6 · Cited by 39
Environment-specific tolerance to nicotine
Epstein, L. H., Caggiula, A. R., & Stiller, R. L. (1989) · Psychopharmacology · doi:10.1007/bf00442256 · Cited by 39
Tobacco/nicotine and endogenous brain opioids
Xue, Y., & Domino, E. F. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.12.012 · Cited by 38
Behavioral performance effects of nicotine in smokers and nonsmokers
Perkins, K. A., Epstein, L. H., Stiller, R. L., Sexton, J. E., Debski, T. T., & Jacob, R. G. (1990) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(90)90035-g · Cited by 38
Chronic nicotine treatment potentiates behavioral responses to dopaminergic drugs in rats
Suemaru, K., Gomita, Y., Furuno, K., & Araki, Y. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90329-r · Cited by 37
Preferential Stimulation of Locomotor Activity by Ventral Tegmental Microinjections of (—)‐Nicotine
Leikola‐Pelho, T., & Jackson, D. M. (1992) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1992.tb00425.x · Cited by 37
Nicotine induced locomotor activity in rats: The role of Pavlovian conditioning
Hakan, R. L., & Ksir, C. J. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90184-0 · Cited by 37
Anxiolytic effects of nicotine in a rodent test of approach-avoidance conflict
Cohen, A., Young, R. W., Velazquez, M. A., Groysman, M., Noorbehesht, K., Ben-Shahar, O. M., & Ettenberg, A. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1486-7 · Cited by 36
Some effects of nicotine on food and water intake in undeprived rats
Clarke, P. B. S., & Kumar, R. (1984) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1984.tb16463.x · Cited by 36
Self-citation
Metadata
- Authors
- Clarke, P. B. S., & Kumar, R.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1983-02
- Volume
- 78
- Issue
- 2
- Pages
- 329-337
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC2044704
- OpenAlex
- W2054668681
- Cited by
- 457
- References
- 30
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 7 · 2021: 1 · 2020: 5 · 2019: 8 · 2018: 4 · 2017: 9 · 2016: 6 · 2015: 11 · 2014: 8 · 2013: 7 · 2012: 12
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@McGill (McGill) (submittedVersion)
- Funders
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- nicotine, locomotor activity, nicotine tolerance, mecamylamine, hexamethonium, nicotinic acetylcholine receptors, dose-dependent effects
- MeSH terms
- Animals, Dose-Response Relationship, Drug, Drug Tolerance, Hexamethonium Compounds, Humans, Male, Mecamylamine, Motor Activity, Nicotine, Substance Withdrawal Syndrome, Hexamethonium, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review